Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Goodwill & Intangibles (2019 - 2025)

Legend Biotech filings provide 7 years of Goodwill & Intangibles readings, the most recent being $2.1 million for Q2 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 22.91% to $2.1 million in Q2 2025 year-over-year; TTM through Jun 2025 was $2.1 million, a 22.91% decrease, with the full-year FY2024 number at $2.2 million, down 46.81% from a year prior.
  • Goodwill & Intangibles hit $2.1 million in Q2 2025 for Legend Biotech, up from $2.1 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $5.4 million in Q3 2021 to a low of -$1.7 million in Q4 2021.
  • Median Goodwill & Intangibles over the past 5 years was $2.6 million (2024), compared with a mean of $2.7 million.
  • The widest YoY moves for Goodwill & Intangibles: up 521205.18% in 2021, down 414.37% in 2021.
  • Legend Biotech's Goodwill & Intangibles stood at -$1.7 million in 2021, then surged by 298.43% to $3.4 million in 2022, then grew by 19.13% to $4.1 million in 2023, then tumbled by 46.81% to $2.2 million in 2024, then fell by 1.06% to $2.1 million in 2025.
  • The last three reported values for Goodwill & Intangibles were $2.1 million (Q2 2025), $2.1 million (Q1 2025), and $2.2 million (Q4 2024) per Business Quant data.